Myricx Bio
London, GB · 3 known investors
Myricx is a biotech company developing a new class of payloads for antibody drug conjugates (ADCs) based on inhibitors of N-myristoyltransferase (NMT) enzymes, aimed at treating cancer. Its pipeline targets solid tumour associated antigens in oncology.
BiotechMedical Devices
Investors · 3
Frequently asked questions
- What does Myricx Bio do?
- Myricx is a biotech company developing a new class of payloads for antibody drug conjugates (ADCs) based on inhibitors of N-myristoyltransferase (NMT) enzymes, aimed at treating cancer. Its pipeline targets solid tumour associated antigens in oncology.
- Who are Myricx Bio's investors?
- Myricx Bio's investors include Brandon Capital Partners, Novo Holdings, Sofinnova Partners.
- Where is Myricx Bio headquartered?
- Myricx Bio is headquartered in London, GB.